PDA TR 81

Technical Report No. 81 (TR 81) Cell-Based Therapy Control Strategy

Parenteral Drug Association , 2019

Publisher: PDA

File Format: PDF

$162.00$325.00


PDA TR 81 focuses on the development of a risk-based control strategy adapted to cell-based therapy that can mitigate the risk of generating a product of poor quality.

More PDA Standards PDF

PCI MNL-140

PCI MNL-140

$104.00 $209.00

PCI MNL-140-12

PCI MNL-140-12

$104.00 $209.00

NZS 8603:2005A1

NZS 8603:2005A1

$93.00 $186.95

NZS 5465:2001A1

NZS 5465:2001A1

$119.00 $238.94